Paragon 28, Inc. (NYSE: FNA) is a leading medical device company exclusively focused on the foot and ankle orthopedic market. The Company designs products with the patient and surgeon in mind to improve outcomes, reduce ailment recurrence and complication rates, and make the procedures simpler,...
BIOLASE, Inc. (NASDAQ: BIOL) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company’s innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE, Inc. (NASDAQ: BIOL) Market Cap: $610.56M; Current...
Cosmos Health Inc., (NASDAQ: COSM), is an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications and medical devices through an extensive, established EU and UK distribution network. The Company identifies, acquires, develops and...
Gritstone Bio, Inc. (NASDAQ: GRTS), formerly known as Gritstone Oncology, is a clinical-stage biotechnology company developing targeted immunotherapies for a range of diseases in the cancer and infectious disease space. The Company’s approach is based on leveraging the inherent abilities of the immune system to...
Ontrak Inc (NASDAQ: OTRK), a virtual provider of AI-powered Telehealth solutions announced the signing of an updated contract with Health Alliance Medical Plans that extends their partnership, which originally began in 2015, to offer uninterrupted access to critical behavioral healthcare for the Medicare and commercial...
MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company that is leveraging its unique Technosphere Technology, to develop and commercialize inhaled therapeutics, for the treatment of endocrine and orphan lung diseases. The Company’s work is based on the foresight of the visionary inventor and Alfred E....
Know Labs, Inc. (OTCQB: KNWN) formerly known as Visualant, is a premier non-invasive medical diagnostics company that is leveraging its proprietary electromagnetic energy technology platforms, namely ChromaID and Bio-RFID technologies, to capture the unique molecular signature of any substance or material. The Company shared preliminary study...
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company, is developing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, an approach that has the potential to address the unmet needs in cardiovascular, metabolic and fatty liver diseases. The Company’s research is...
Misonix, Inc. (NASDAQ: MSON) is building a highly differentiated surgical ultrasonic technology portfolio, to address and improve patient outcomes in neurosurgery, spine surgery, general surgery, orthopedic surgery, wound debridement, and craniomaxillofacial surgery. A world-class specialist in Ultrasonic technology, the Company’s products and services find their...
MediWound Ltd (NASDAQ: MDWD), a Company creating cutting-edge solutions for tissue repair and regeneration, recently announced its Q4 and Full-year 2020 Financial results. While the revenue was up by 23 percent, at $6.7 Million, compared to $5.4 million for the same period in 2019, product revenues...
